File:Lenalidomide molecular structure.jpg: Difference between revisions
From Embryology
(==Lenalidomide Molecular Structure== (CC-5013, Revlimid) A derivative of thalidomide introduced in 2004, initially intended as a treatment for multiple myeloma. Has also shown efficacy in the hematological disorders, myelodysplastic syndromes. Molecula) |
(uploaded a new version of "File:Lenalidomide molecular structure.jpg") |
| (One intermediate revision by the same user not shown) | |
(No difference)
| |
Latest revision as of 13:27, 1 September 2012
Lenalidomide Molecular Structure
(CC-5013, Revlimid) A derivative of thalidomide introduced in 2004, initially intended as a treatment for multiple myeloma. Has also shown efficacy in the hematological disorders, myelodysplastic syndromes.
Molecular Formula: C13H13N3O3 Molecular Weight: 259
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 13:27, 1 September 2012 |  | 500 × 500 (20 KB) | Z8600021 (talk | contribs) | |
| 13:25, 1 September 2012 |  | 500 × 500 (20 KB) | Z8600021 (talk | contribs) | ||
| 13:23, 1 September 2012 |  | 500 × 500 (16 KB) | Z8600021 (talk | contribs) | ==Lenalidomide Molecular Structure== (CC-5013, Revlimid) A derivative of thalidomide introduced in 2004, initially intended as a treatment for multiple myeloma. Has also shown efficacy in the hematological disorders, myelodysplastic syndromes. Molecula |
You cannot overwrite this file.
File usage
The following 2 pages use this file:
